Dr. Reddy's Laboratories
RDY
#1841
Rank
NZ$18.70 B
Marketcap
NZ$22.28
Share price
1.13%
Change (1 day)
-9.61%
Change (1 year)

Market capitalization of Dr. Reddy's Laboratories (RDY)

Market cap: NZ$18.70 Billion

As of February 2026 Dr. Reddy's Laboratories has a market cap of NZ$18.70 Billion. This makes Dr. Reddy's Laboratories the world's 1841th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Dr. Reddy's Laboratories from 2001 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$18.70 B-8.52%
2025NZ$20.45 B-14.34%
2024NZ$23.87 B29.43%
2023NZ$18.44 B36.27%
2022NZ$13.53 B-15.52%
2021NZ$16.02 B-1.66%
2020NZ$16.29 B64.63%
2019NZ$9.89 B6.97%
2018NZ$9.25 B5.1%
2017NZ$8.80 B-18.27%
2016NZ$10.77 B-7.42%
2015NZ$11.63 B4.56%
2014NZ$11.12 B31.16%
2013NZ$8.48 B23.07%
2012NZ$6.89 B6.69%
2011NZ$6.46 B-20.55%
2010NZ$8.13 B42.21%
2009NZ$5.71 B103.97%
2008NZ$2.80 B-29.66%
2007NZ$3.98 B-8.06%
2006NZ$4.33 B79.3%
2005NZ$2.41 B13.72%
2004NZ$2.12 B-42.92%
2003NZ$3.72 B31.82%
2002NZ$2.82 B-19.06%
2001NZ$3.49 B

End of Day market cap according to different sources

On Jan 31st, 2026 the market cap of Dr. Reddy's Laboratories was reported to be:

NZ$18.59 Billion
by Nasdaq info icon info icon
NZ$18.70 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novartis
NVS
NZ$473.68 B 2,431.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$249.60 B 1,234.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$189.70 B 914.04%๐Ÿ‡ซ๐Ÿ‡ท France
GSK plc
GSK
NZ$173.15 B 825.57%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$64.92 B 247.02%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel